Hey OFIX,are you are missing the rally?

Quote






Anonymous said:
Hmmmmm. No trades since 11 am yesterday, preceded by a bit of a rally. Anybody got comment???
Click to expand...

57,000 shares traded which is not huge volume but still activity. No Biggie. Stock is in trader range the last 6 moths. Sell at $23, but it back around $20, sell it again at $23 and buy it back around $20. Outside of that Ofix can lay in limbo the next yr and the stock teeter between $20-$23. That of course is until the shit hits the fan and they get de-listed or Ofix files to go private. They still generate give or take around $400k in revenue with all the divisions combined, so it's still a bonafide company in spite of what the haters say and think. Certainly, it's not a company on the move and it is going backwards in sales. At some point, they will level off and the bleeding will stop and the sales will start moving forward again. But, it's anybodies guess when they might happen again......
 






4-Mar-2014

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or



Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
As previously reported, on February 11, 2014, Orthofix International N.V. (the "Company") received an expected letter from the Listing Qualifications Department of the NASDAQ Stock Market (the "NASDAQ Staff") stating that unless the Company requests a hearing before a NASDAQ Listing Qualifications Panel (a "NASDAQ Hearings Panel") by February 18, 2014, the Company's common stock would be subject to delisting based upon the Company's current non-compliance with NASDAQ Listing Rule 5250(c)(1) as a result of certain delinquent Securities and Exchange Commission reports. On February 18, 2014, the Company requested an appeal of the NASDAQ Staff determination, and also requested an extension of the automatic 15-day stay of the suspension of the delisting of the Company's common stock pending a hearing by a NASDAQ Hearings Panel.

On February 27, 2014, the Company received a letter from NASDAQ's Office of General Counsel stating that a NASDAQ Hearings Panel had granted the Company's request for a stay of the delisting of the Company's common stock until such time as the NASDAQ Hearings Panel makes a decision on the merits following a hearing, which hearing has been scheduled for March 27, 2014. The letter further states that, accordingly, the Company's common stock will continue to trade on the NASDAQ Stock Market pending the March 27, 2014 hearing and the issuance of a final decision by the NASDAQ Hearings Panel thereafter.





Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Amendment No. 1 to Employment Agreement with Emily Buxton

On January 7, 2013, the Company, through its subsidiary Orthofix Inc., entered into an employment agreement (the "Original Agreement") with Emily Buxton, the Company's then-Interim Chief Financial Officer (and, since April 1, 2013, Chief Financial Officer). The Original Agreement was described in and filed with the Company's Current Report on Form 8-K dated January 11, 2013.

On February 27, 2014, the Company and Ms. Buxton entered into Amendment No. 1 to the Original Agreement (the "Amendment"). The Amendment was authorized and approved on the same date by the Compensation Committee of the Company's Board of Directors.

The Amendment provides that Ms. Buxton will receive a special retention cash bonus in an aggregate amount of $195,000, payable (i) 50% in amount on the date that the Company has filed each of (A) its financial statement restatement for the 2011 and 2012 fiscal years and the first fiscal quarter of 2013, (B) its Quarterly Reports on Form 10-Q for the second and third fiscal quarters of 2013, and (C) its Annual Report on Form 10-K for the 2013 fiscal year (the first date by which all such filings have been made, the "Filing Completion Date"), and
(ii) 50% in amount on the date that is six months following the Filing Completion Date. Both portions of the bonus are contingent upon Ms. Buxton remaining employed by the Company on the applicable payment date (unless her employment has been terminated by the Company without "Cause" or by her for "Good Reason" prior to such payment date, in which case it shall remain payable on the applicable payment date). The Amendment also (i) amends the definition of "Good Reason" under the agreement to provide that "Good Reason" will exist if Ms. Buxton's duties following the Filing Completion Date no longer include serving as the Company's Chief Financial Officer, and (ii) reflects salary and bonus target terms that have been in effect since Ms. Buxton was promoted from Interim Chief Financial Officer to Chief Financial Officer in April 1, 2013 (and which were previously reflected in the Company's prior proxy statement disclosure in April 2013).

The foregoing description of the Amendment is a summary of material terms thereof, and is qualified in its entirety by the text of the Amendment, a copy of which is filed herewith as Exhibit 10.1 and incorporated herein by reference.





Item 9.01. Financial Statements and Exhibits.
(d) Exhibits

10.1 Amendment No. 1 to Employment Agreement, entered into on February 27, 2014, by and between Orthofix Inc. and Emily Buxton
 










































Anonymous said:
Their filings do not support your statement whatsoever.
Click to expand...

February 6

"The Company, in coordination with the Audit Committee of the Company’s Board of Directors, is currently preparing the financial restatement and the Delinquent Reports, and substantial progress has been made in that regard. The Company intends to complete the restatement and file the Delinquent Reports as promptly as practicable, and is currently proceeding with the objective of completing this process (including the filing of the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2013) by the end of the first quarter of 2014."

Idiot...
 
























Anonymous said:
we'll see.
Click to expand...

No, not we will see, this actually happened. It's factual.

Now, whether it stays there or it goes up is another story. My personal feeling is that the numbers with be really bad and the stock will go to the low teens and settle or OFIX files to go private. Now, if they stay public, the base line will be reset again, creating a potential buying opportunity. If I was in Ofix executive shoes, I would want to flush the toilet, let the stock go down to low teens, reset the baseline, and starting moving the needle forward and make a fortune riding it back to the 20's and up. That's how these CEO's make millions on turning problems into opportunities.
 
























Anonymous said:
Yes, I am short about 5% of the cap. Even if it doesn't delist, there's nothing going to come out that will support $25.....LOL
Click to expand...

duffas -The total short interest on OFIX is 3.04% of market cap at the moment....

Assuming you, in your fantasy world, are short 5% of the cap, and making the assumption that you sold short a few weeks ago when it was $22/share, then you officially hit a MARGIN CALL today.... CONGRATULATIONS!

Deposit $10,450,000 to sell short 950,000 shares of OFIX at $22.00. Borrow $10,450,000 from broker.

Margin = Equity/CMV

so based on today's closing price of $25.38,

.30 = $7,239,000/$24,111,000

You hit the magic margin maintenance requirement today!
 












Top Bottom
Back
Quote